Table 2.

Adherence to assessment time points

			All participants		Intervention group		Control group
			N*	%	N*	%	N*	%
Exercise assessment	Performance diagnostics	T0†	14/15	93.3	7/8	87.5	7/7	100.0
		T1	11/15	73.3	6/8	75.0	5/7	71.4
		T2	12/13	92.3	6/6	100.0	6/7	85.7
		T3	11/11	100.0	5/5	100.0	6/6	100.0
		T0 – T3	48/54	88.9	24/27	88.9	24/27	88.9
	Accelerometer‡	T0	13/15	86.7	6/8	75.0	7/7	100.0
		T1	11/15	73.3	6/8	75.0	5/7	71.4
		T2	10/13	76.9	5/6	83.3	5/7	71.4
		T3	11/11	100.0	5/5	100.0	6/6	100.0
		T0 – T3	45/54	83.3	22/27	81.5	23/27	85.2
Nutrition diagnostics		T0	14/15	93.3	8/8	100.0	6/7	85.7
		T1	15/15	100.0	8/8	100.0	7/7	100.0
		T2	12/13	92.3	6/6	100.0	6/7	85.7
		T3	11/11	100.0	5/5	100.0	6/6	100.0
		T0 – T3	52/54	96.3	27/27	100.0	25/27	92.6
Case report form§		T0	15/15	100.0	8/8	100.0	7/7	100.0
		T1	15/15	100.0	8/8	100.0	7/7	100.0
		T2	12/13	92.3	6/6	100.0	6/7	85.7
		T3	11/11	100.0	5/5	100.0	6/6	100.0
		T0 – T3	53/54	98.2	27/27	100.0	26/27	96.3

*Number of participants assessed/number eligible.

†T0 = baseline, T1=mid-chemotherapy, T2=after completion of chemotherapy, T3=1-year follow-up.

‡Worn at home for a week at each time of assessment.

§Included all questionnaires applied In the study.